Edward J. Osborne, PhD

Adaptive BIotechnologies
Seattle, Washington, United States

Adaptive Biotechnologies (Employee, Shareholder)

Presentation(s):

• 126 - Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection and Vaccination

  On Demand